• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[新冠疫情与医学出版物：三篇文章如何影响了法国的媒体和公众决策]

[COVID-19 and medical publications: How three articles have influenced the media and public decisions in France].

作者信息

Péretz F, Bonini-Vuillod J, Grivaux M, Duracinsky M, Chassany O

机构信息

Abelia Science, 1, allée des Sablons, 89000 Saint-Georges-sur-Baulche, France.

Abelia Science, 1, allée des Sablons, 89000 Saint-Georges-sur-Baulche, France.

出版信息

Rev Med Interne. 2021 Aug;42(8):583-590. doi: 10.1016/j.revmed.2021.03.010. Epub 2021 Mar 23.

DOI:10.1016/j.revmed.2021.03.010
PMID:33771408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7986470/
Abstract

The present article details the publication process and the vicissitudes of three articles about SARS-CoV-2 and its related disease (COVID-19). The three articles were published one month apart between March and May 2020. Their mediatization led French health authorities to intervene. Our article does not focus on and does not assess the scientific quality of the articles presented, but only aims to open the reflection on medical publication. Beyond the description of these three specific cases, this article raises issues about article retraction, peer-reviewing, preprints, authorship and the dissemination of scientific medical information, including through the mass media. It discusses new publishing modes and the dissemination of published information in clinical research.

摘要

本文详细介绍了三篇关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其相关疾病（新冠肺炎）的文章的发表过程及变迁。这三篇文章于2020年3月至5月期间相隔一个月发表。它们的媒体化导致法国卫生当局进行干预。我们的文章并不关注也不评估所呈现文章的科学质量，而仅旨在开启关于医学出版物的思考。除了对这三个具体案例的描述之外，本文还提出了关于文章撤回、同行评审、预印本、作者身份以及科学医学信息传播（包括通过大众媒体传播）等问题。它讨论了临床研究中的新出版模式以及已发表信息的传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c211/7986470/43e19a4953a1/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c211/7986470/014575e3dee0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c211/7986470/fa22da5b5a3b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c211/7986470/5b33e16446a3/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c211/7986470/43e19a4953a1/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c211/7986470/014575e3dee0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c211/7986470/fa22da5b5a3b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c211/7986470/5b33e16446a3/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c211/7986470/43e19a4953a1/gr4_lrg.jpg

相似文献

1
[COVID-19 and medical publications: How three articles have influenced the media and public decisions in France].[新冠疫情与医学出版物：三篇文章如何影响了法国的媒体和公众决策]
Rev Med Interne. 2021 Aug;42(8):583-590. doi: 10.1016/j.revmed.2021.03.010. Epub 2021 Mar 23.
2
Tracking changes between preprint posting and journal publication during a pandemic.追踪大流行期间预印本发布和期刊出版之间的变化。
PLoS Biol. 2022 Feb 1;20(2):e3001285. doi: 10.1371/journal.pbio.3001285. eCollection 2022 Feb.
3
Social Media and Research Publication Activity During Early Stages of the COVID-19 Pandemic: Longitudinal Trend Analysis.社交媒体与 COVID-19 大流行早期阶段的研究出版活动：纵向趋势分析。
J Med Internet Res. 2021 Jun 17;23(6):e26956. doi: 10.2196/26956.
4
Publishing in pandemic times: A bibliometric analysis of early medical publications on Kawasaki-like disease (MIS-C, PIMS-TS) related to SARS-CoV-2.大流行时期的出版：与 SARS-CoV-2 相关的川崎病样疾病（MIS-C、PIMS-TS）早期医学出版物的文献计量分析。
Arch Pediatr. 2021 Aug;28(6):464-469. doi: 10.1016/j.arcped.2021.05.002. Epub 2021 May 28.
5
Rapid publications risk the integrity of science in the era of COVID-19.在 COVID-19 时代，快速发表文章有危害科学的完整性的风险。
BMC Med. 2020 Jun 25;18(1):192. doi: 10.1186/s12916-020-01650-6.
6
Contradictions in the promotion of publishing academic and scientific journal articles, and the inability to cope with the new coronavirus (COVID-19).学术和科学期刊文章出版的矛盾，以及无法应对新型冠状病毒（COVID-19）。
Antimicrob Resist Infect Control. 2021 Jan 12;10(1):10. doi: 10.1186/s13756-021-00884-0.
7
Preprint manuscripts and servers in the era of coronavirus disease 2019.2019 冠状病毒病时代的预印本手稿和服务器。
J Eval Clin Pract. 2021 Feb;27(1):16-21. doi: 10.1111/jep.13498. Epub 2020 Oct 23.
8
COVID-19-related medical research: a meta-research and critical appraisal.COVID-19 相关医学研究：元研究与批判性评价。
BMC Med Res Methodol. 2021 Jan 4;21(1):1. doi: 10.1186/s12874-020-01190-w.
9
Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals.在世界领先的医学期刊上发表的关于 COVID-19 的文章中引用 medRxiv 预印本的可靠性。
PLoS One. 2022 Aug 10;17(8):e0264661. doi: 10.1371/journal.pone.0264661. eCollection 2022.
10
The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape.预印本在 COVID-19 研究传播中的作用演变及其对科学传播格局的影响。
PLoS Biol. 2021 Apr 2;19(4):e3000959. doi: 10.1371/journal.pbio.3000959. eCollection 2021 Apr.

引用本文的文献

1
The use and acceptability of preprints in health and social care settings: A scoping review.预印本在卫生和社会保健环境中的使用和可接受性：范围综述。
PLoS One. 2023 Sep 15;18(9):e0291627. doi: 10.1371/journal.pone.0291627. eCollection 2023.

本文引用的文献

1
The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape.预印本在 COVID-19 研究传播中的作用演变及其对科学传播格局的影响。
PLoS Biol. 2021 Apr 2;19(4):e3000959. doi: 10.1371/journal.pbio.3000959. eCollection 2021 Apr.
2
Publication by association: how the COVID-19 pandemic has shown relationships between authors and editorial board members in the field of infectious diseases.关联发表：COVID-19 大流行如何显示传染病领域作者与编委会成员之间的关系。
BMJ Evid Based Med. 2022 Jun;27(3):133-136. doi: 10.1136/bmjebm-2021-111670. Epub 2021 Mar 30.
3
Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
近期文献不支持将羟氯喹与阿奇霉素联合用于治疗COVID-19患者。
Int J Antimicrob Agents. 2021 Jan;57(1):106241. doi: 10.1016/j.ijantimicag.2020.106241.
4
Tobacco and COVID-19: a crisis within a crisis?烟草与 COVID-19：危机中的危机？
Can J Public Health. 2020 Dec;111(6):995-999. doi: 10.17269/s41997-020-00427-x. Epub 2020 Oct 14.
5
A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19.系统评价和荟萃分析住院吸烟者与 COVID-19 。
Int J Environ Res Public Health. 2020 Oct 11;17(20):7394. doi: 10.3390/ijerph17207394.
6
Learning from a retraction.从撤稿中吸取教训。
Lancet. 2020 Oct 10;396(10257):1056. doi: 10.1016/S0140-6736(20)31958-9. Epub 2020 Sep 17.
7
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.一种与 COVID-19 相关的烟碱能假说及其预防和治疗意义。
C R Biol. 2020 Jun 5;343(1):33-39. doi: 10.5802/crbiol.8.
8
Research in the Context of a Pandemic.大流行背景下的研究
N Engl J Med. 2021 Feb 25;384(8):755-757. doi: 10.1056/NEJMe2024638. Epub 2020 Jul 17.
9
Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949.《羟氯喹啉和阿奇霉素治疗新型冠状病毒肺炎：一项开放标签非随机临床试验的结果》综述 Gautret等人，2010年，DOI:10.1016/j.ijantimicag.2020.105949
Int J Antimicrob Agents. 2020 Jul;56(1):106063. doi: 10.1016/j.ijantimicag.2020.106063. Epub 2020 Jul 13.
10
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤稿——羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册研究分析
Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Epub 2020 Jun 5.